Free shipping on all orders over $ 500

 About 1 result found for searched term "1643672-70-1" (0.122 seconds)

Cat.No.  Name Target
M24769 Frovocimab PCSK9
LY 3015014
Frovocimab (LY 3015014) is a humanized IgG4 monoclonal antibody (mAb) that neutralizes PCSK9. Frovocimab inhibits PCSK9 binding to LDL receptor (LDLR) while permitting the normal proteolytic cleavage of the bound intact PCSK9.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.